Critères de sélection pour la chimiothérapie des personnes âgées

The growing proportion of elderly (over 70 years) with multiple comorbidities and an aging physiological metabolic functions should lead us to revise our treatment proposals The development of geriatric oncology, through the establishment of geriatric scale assessing the patient in a simple and multidimensional, will select a more homogeneous population of patients in terms of response and survival, and they be given a more appropriate treatment.